Probiotics in Systemic Lupus Erythematosus
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Systemic Lupus Erythematosus
Related studies linked through entity extraction aliases.
Study of Daxdilimab (HZN-7734) for the Treatment of Systemic Lupus Erythematosus in an Open-label Extension Study
- Status
- TERMINATED
- Phase
- PHASE2
Vitamin D and Curcumin Piperine Attenuates Disease Activity and Cytokine Levels in Systemic Lupus Erythematosus Patients
- Status
- COMPLETED
- Phase
- PHASE2
Utilizing Qualitative and Quantitative Methods to Understand a New Model of Type 1 and 2 Systemic Lupus Erythematosus (SLE)
- Status
- COMPLETED
- Phase
- NA
Myeloid Derived Suppressor Cells in Systemic Lupus Erythematosus
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Clinical Characteristics and Outcomes of SLE Patients Admitted to Critical Care Unit
- Status
- UNKNOWN
- Phase
- N/A
Progressive Resisted Exercise Plus Aerobic Exercise on Osteoporotic Systemic Lupus Erythmatosus
- Status
- COMPLETED
- Phase
- NA
Laser Puncture and Program of Lifestyle Modification in Lupus Females
- Status
- UNKNOWN
- Phase
- NA
Prediction of Lupus Renal Flares Study
- Status
- UNKNOWN
- Phase
- N/A
Precision Medicine in LN: A Multicenter Proof-of-concept Study for Histopathological Biomarkers Analysis in Renal Biopsy
- Status
- UNKNOWN
- Phase
- N/A
ELEVATE - (Empower Lupus Erythematosus Patients Via Allowing RemoTe Evaluation)
- Status
- COMPLETED
- Phase
- N/A
Efficacy and Immunological Evaluation of Telitacicept and Low Dose IL2 in the Treatment of Systemic Lupus Erythematosus
- Status
- RECRUITING
- Phase
- PHASE3
Effects of Telehealth Initiative on Lupus Patients
- Status
- COMPLETED
- Phase
- NA
A Phase Ia Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Subcutaneously Administered CUG252 in Normal Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Vagus Nerve Stimulation for Systemic Lupus Erythematous
- Status
- COMPLETED
- Phase
- NA
Examining Distinct Immunophenotypes to Validate and Enhance Rational Treatment in Systemic Lupus
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Telitacicept for the Treatment of Moderately to Severely Active Systemic Lupus Erythematosus (REMESLE-1)
- Status
- TERMINATED
- Phase
- PHASE3
Monıtorıng Glucocortıcoıd Treatment In Patıents Followed In Rheumatology Clınıc
- Status
- UNKNOWN
- Phase
- N/A
Motivating Individuals With Lupus to Exercise
- Status
- COMPLETED
- Phase
- NA
Efficacy and Immunological Evaluation of Belimumab Plus Low Dose IL-2 in the Treatment of Systemic Lupus Erythematosus
- Status
- UNKNOWN
- Phase
- PHASE3